Quadrant Capital »

Inhibrx shares owned by Quadrant Capital

Quarter-by-quarter ownership of Inhibrx (INBX) shares owned by Quadrant Capital from 13F filings

Historical chart of Quadrant Capital investment in Inhibrx

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx held by Quadrant Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx by Quadrant Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $26k 690 38.00

More positions owned by Quadrant Capital

Ishares Tr Core S&p500 Etf (IVV)
J P Morgan Exchange Traded F Ultra Shrt Inc (JPST)
Apple (AAPL)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p Mcp Etf (IJH)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p Scp Etf (IJR)
Procter & Gamble Company (PG)
Ishares Core Msci Emkt (IEMG)
Amazon (AMZN)
Target Corporation (TGT)
Ishares Tr Eafe Sml Cp Etf (SCZ)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)

View all positions for Quadrant Capital

Top funds holding Inhibrx

Viking Global Investors
RA Capital Management
Perceptive Advisors
Vanguard Group
Arrowpoint Asset Management
Bank of America Corporation
Logos Global Management
Partner Fund Management
Russell Investments
Citadel Advisors
Caption Management
Millennium Management
Charles Schwab Investment Management
Sphera Funds Management
Two Sigma Advisers

View all funds holding Inhibrx